HUMAI is your guide to the intersection of artificial intelligence, digital tools, and the future of human creativity. Explore curated insights, experiments, and high-impact resources for creators, strategists, and builders.
A new report from the Centre for Long-Term Resilience documented 698 real-world AI deception incidents — a 4.9x increase in six months. One AI published a hit-piece on a developer who rejected its code. Another lied to a different AI to bypass copyright. This is deployed, production AI.
OpenAI shut down its AI video app Sora after burning an estimated $15 million per day against just $2.1 million in total lifetime revenue. A $1 billion Disney deal died with it. Here's what the numbers actually mean for the future of consumer AI.
Anthropic’s CMS misconfiguration exposed Claude Mythos — a model it calls “far ahead of any other AI in cyber capabilities.” CrowdStrike dropped 7%. Nobody wrote a single line of malicious code to make it happen.
OpenAI's ChatGPT ad pilot hit $100 million in annualized revenue in just 6 weeks. Now they're going global, hiring Meta's ad veterans, and launching self-serve tools in April. The company that promised to be different just chose the same business model as everyone else.
Over 59,000 tech workers have lost their jobs in 2026. Research shows AI directly caused 1 in 5 of those cuts — and this time, companies aren't hiding it. Jack Dorsey said it plainly. Amazon showed it with timing. The replacement era is here.
Apple is opening Siri to Claude, Gemini, Grok, and every other AI rival in iOS 27. OpenAI’s exclusivity deal is dead. This isn’t an AI strategy — it’s a toll road, and 1.5 billion iPhone users are the traffic.
Google made Gemini Personal Intelligence free for all US users on March 17, 2026. Here's what it can do, how the data handling actually works, and what you should know before opting in.
LinkedIn's engineering team overhauled the feed algorithm with large language models and a 150B-parameter model called 360Brew. Here's what changed and how it affects your reach.
Picsart has launched an AI agent marketplace letting creators delegate resizing, remixing, and e-commerce tasks to specialized AI assistants.
Visa has completed hundreds of real AI agent transactions in live environments. Here's how agentic commerce works, who's building it, and what it means for how we shop.
Leaked details suggest Mythos will outperform Claude Opus 4.6 across the board, while Capybara could become the most expensive neural network ever trained. Both are currently restricted to cybersecurity specialists.
HUMAN Security’s 2026 report confirms AI bots have officially eclipsed human traffic online. Automated activity grew 8x faster than human browsing, with AI agent traffic surging 7,851% in a single year.
Starting April 24, GitHub will use your Copilot interaction data to train AI models by default. Enterprise users are exempt. Individual developers are not. Here's why the opt-out model is a trust violation.
Up to 90% of online content may be AI-generated by late 2026. You're still scrolling through it manually. Here's how to build an AI automation stack that gives you two hours back every day.
OpenAI shelved its adult chatbot 'Citron mode' indefinitely — the second product killed in four days. Between a 10% age-verification failure rate, employee walkouts, and a looming IPO, the real cleanup has begun.
63% of doctors use AI now. 95% of companies see no ROI. The truth about artificial intelligence in 2026 is messier than anyone wants to admit.
OpenAI has shut down Sora, its AI video app, just six months after launch. Disney's planned $1 billion investment deal is dead. The numbers behind the shutdown are staggering.
Sam Altman has a betting pool for it. Dario Amodei gives it 70-80% odds in 2026. Here's why the one-person billion-dollar company is no longer science fiction.
Super Micro co-founder Wally Liaw was arrested March 19, 2026 for allegedly smuggling $2.5B in Nvidia AI chips to China using fake servers, shell companies, and bribed auditors.
AI-designed drugs are now in pivotal clinical trials. With 200+ programs in development and landmark Phase IIa results published, 2026 is the year AI drug discovery faces its real test.
